The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes ( nPOD ) Program: goals, operational model and emerging findings
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Type 1 diabetes (T1D) is considered an autoimmune disease, predominantly mediated by autoreactive T cell responses, which over time leads to the destruction of pancreatic beta cells and insulin deficiency.Symptoms often appear in childhood or adolescence, but the disease can develop in adult patients as well (1).Both therapeutic management and clinical outcomes have dramatically improved during the last few decades, yet T1D remains a major cause of suffering, a burden to society, and its incidence appears to be increasing, especially in younger children (2).Although we can identify individuals at increased risk among patients' relatives, the disease cannot be prevented and there is no definitive cure (3).Pancreas and islet transplantation can restore insulin independence, at least for a period of time, but are not universally available and require chronic immunosuppression (4).The partial success of human clinical trials aimed at ameliorating islet autoimmunity likely reflects our incomplete knowledge of etiological factors and the limited understanding of the key pathogenic mechanisms that cause the disease (1, 3).Our ability to study the disease has been hampered by scarce access to the pancreas and other disease-related tissues.The limited data available from studies of human pancreata from patients have been to a large extent, from pancreata obtained several decades ago that were not studied with modern technologies.Furthermore, they may no longer reflect current disease, particularly as they relate to etiological factors if these vary over time.Our views of the disease pathogenesis have been largely shaped by studies in experimental rodent models of the disease, especially the non-obese diabetic (NOD) mouse ( 5).Yet critical questions regarding disease pathogenesis are specific to humans and cannot be easily investigated in experimental animals.Among these are: (i) the nature (phenotypically and functionally) of autoreactive T and B cells, which may be therapeutically targeted; (ii) the role of viral infections, which could perhaps be averted
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113 · cited 2×
“Our views of the disease pathogenesis have been largely shaped by studies in experimental rodent models of the disease, especially the non-obese diabetic (NOD) mouse (5).”
BackgroundPugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945
Self-citationCoppieters, K. T., Dotta, F., Amirian, N., Campbell, P. D., Kay, T. W. H., Atkinson, M. A., Roep, B. O., & von Herrath, M. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111187 · Cited by 672
Self-citationKeenan, H. A., Sun, J. K., Levine, J., Doria, A., Aiello, L. P., Eisenbarth, G., Bonner-Weir, S., & King, G. L. (2010) · Diabetes · doi:10.2337/db10-0676 · Cited by 500 · cited 1×
“This is direct pathological evidence of the chronicity of the disease process, which challenges the classical concept that beta cells destruction is almost complete by the time of diagnosis and is aligned with recent clinical studies demonstrating long-term C-peptide persistence in some patients with T1D (26, 47).”
Butler, A. E., Campbell-Thompson, M., Gurlo, T., Dawson, D. W., Atkinson, M., & Butler, P. C. (2013) · Diabetes · doi:10.2337/db12-1686 · Cited by 457
Self-citationFormation of a human β-cell population within pancreatic islets is set early in life
Gregg, B. E., Moore, P. C., Demozay, D., Hall, B. A., Li, M., Husain, A., Wright, A. J., Atkinson, M. A., & Rhodes, C. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1206 · Cited by 344
Self-citationFall in C-Peptide During First 2 Years From Diagnosis
Greenbaum, C. J., Beam, C. A., Boulware, D., Gitelman, S. E., Gottlieb, P. A., Herold, K. C., Lachin, J. M., McGee, P., Palmer, J. P., Pescovitz, M. D., et al. (2012) · Diabetes · doi:10.2337/db11-1538 · Cited by 319
Orban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0934 · Cited by 260 · cited 1×
“This is consistent with investigations of pancreas organ donors from Europe (based on examination of small tissue fragments) (45) and with the low risk of disease progression observed in prospective studies of relatives with a single islet autoantibody (46).”
ResultSelf-citationType 1 diabetes: translating mechanistic observations into effective clinical outcomes
Herold, K. C., Vignali, D. A. A., Cooke, A., & Bluestone, J. A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3422 · Cited by 237
Campbell‐Thompson, M., Wasserfall, C., Kaddis, J., Albanese‐O'Neill, A., Staeva, T., Nierras, C., Moraski, J., Rowe, P., Gianani, R., Eisenbarth, G., et al. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2316 · Cited by 236
Self-citationDimorphic histopathology of long-standing childhood-onset diabetes
Gianani, R., Campbell-Thompson, M., Sarkar, S. A., Wasserfall, C., Pugliese, A., Solis, J. M., Kent, S. C., Hering, B. J., West, E., Steck, A., et al. (2010) · Diabetologia · doi:10.1007/s00125-009-1642-y · Cited by 158
Self-citationRecovery of endocrine function after islet and pancreas transplantation
Rickels, M. R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0294-3 · Cited by 49 · cited 1×
“Pancreas and islet transplantation can restore insulin independence, at least for a period of time, but are not universally available and require chronic immunosuppression (4).”
Background
Cited by
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475
Self-citationPancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Environmental risk factors for type 1 diabetes
Rewers, M., & Ludvigsson, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30507-4 · Cited by 676
The human body at cellular resolution: the NIH Human Biomolecular Atlas Program
HuBMAP Consortium, Writing Group, Snyder, M. P., Lin, S., Posgai, A., Atkinson, M., Regev, A., Rood, J., Rozenblatt-Rosen, O., Gaffney, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1629-x · Cited by 595
Self-citationAutoreactive T cells in type 1 diabetes
Pugliese, A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94549 · Cited by 358
Self-citation
Metadata
- Authors
- Pugliese, A., Yang, M., Kusmarteva, I., Heiple, T., Vendrame, F., Wasserfall, C., Rowe, P., Moraski, J. M., Ball, S., Jebson, L., Schatz, D. A., Gianani, R., Burke, G. W., Nierras, C., Staeva, T., Kaddis, J. S., Campbell‐Thompson, M., & Atkinson, M. A.
- Venue
- Pediatric Diabetes
- Publisher
- Hindawi Limited
- Published
- 2013-12-10
- Volume
- 15
- Issue
- 1
- Pages
- 1-9
- ISSN
- 1399-543X (ISSN-L)
- 1399-5448
- OpenAlex
- W1574138266
- Cited by
- 132
- References
- 12
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.